Papyrus DX

Bengaluru, India Founded: 2021 • Age: 5 yrs
Diagnostic devices for infectious diseases and antimicrobial resistance are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 4 Brand Intelligence

About Papyrus DX

Papyrus DX is a company based in Bengaluru (India) founded in 2021 by Venkata Subramanian Ramesan and Bhushan Toley. The company has 1 employees as of April 07, 2024. Papyrus DX operates in a competitive market with competitors including RAMJA Genosensor, phenofAST, MedFluid and OSPT, among others.

  • Headquarter Bengaluru, India
  • Employees 1 as on 07 Apr, 2024
  • Founders Venkata Subramanian Ramesan, Bhushan Toley
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Papyrus Diagnostics Private Limited
  • Date of Incorporation 07 Jul, 2021
  • Jurisdiction Bangalore North, Karnataka, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$1.1 K (USD)
    0
    as on Mar 31, 2022
  • EBITDA
    -$1.1 K (USD)
    0
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Papyrus DX

Premium access

Detailed funding history for Papyrus DX

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Papyrus DX

Investments
Premium access

Investment portfolio details for Papyrus DX

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Papyrus DX

Premium access

Detailed financials for Papyrus DX

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Papyrus Dx Comparisons

Papyrus DX Primary company
Description
Diagnostic devices for infectious diseases and antimicrobial...
Location
Bengaluru, India
Founded Year
2021
Annual Revenue
Not available
Net Profit
-$1.1 K (USD)
EBITDA
-$1.1 K (USD)
Employees
1
As of 2024
Premium access

Peer comparison for Papyrus DX

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Papyrus DX

Papyrus DX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RAMJA Genosensor, phenofAST, MedFluid and OSPT, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of a smart sensor for the detection of bacterial infection and antibiotic resistance
Locked Locked Locked
Provides comprehensive solutions for antimicrobial susceptibility testing.
Locked Locked Locked
Provides point-of-care molecular diagnostics and antimicrobial susceptibility testing solutions.
Locked Locked Locked
Pioneering antibacterial textiles to combat surgical implant and wound infections.
Premium access

Detailed competitors of Papyrus DX

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Papyrus Dx

Premium access

Complete news archive for Papyrus DX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Papyrus DX

Papyrus DX was founded in 2021.

Papyrus DX is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Venkata Subramanian Ramesan is the current CEO of Papyrus DX. They have also founded this company.

As of Apr 07, 2024, the latest employee count at Papyrus DX is 1.

Papyrus was founded in 2021 in Bengaluru, India, within the health technology sector. Diagnostic solutions for detecting antimicrobial resistance, COVID-19, and other infectious diseases are offered. Specimen transport technology is also provided to support these operations. The focus remains on advancing point-of-care diagnostics for global health challenges, with activities centered in the Indian market.

Papyrus DX's top competitors include RAMJA Genosensor, phenofAST and MedFluid.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available